US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 121.500
  • -1.870-1.52%
Close Dec 27 16:00 ET
  • 121.500
  • 0.0000.00%
Post 20:01 ET
11.61BMarket Cap78.90P/E (TTM)

About Sarepta Therapeutics Company

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Company Profile

SymbolSRPT
Company NameSarepta Therapeutics
Listing DateJun 4, 1997
Issue Price9.00
Founded1980
CEOMr. Christopher Garabedian
MarketNASDAQ
Employees1314
Fiscal Year Ends12-31
Address215 First Street,Suite 415
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-274-4000
Websitehttp://www.sarepta.com

Company Executives

  • Name
  • Position
  • Salary
  • Douglas S. Ingram,Esq.
  • Director, President and Chief Executive Officer
  • 1.66M
  • Dallan Murray
  • Executive Vice President and Chief Customer Officer
  • --
  • Ian Michael Estepan
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 3.71M
  • Louise Rodino-Klapac
  • Executive Vice President, Head of R&D and Chief Scientific Officer
  • 3.72M
  • Bilal Arif
  • Executive Vice President and Chief Technical Operations Officer
  • 3.52M
  • Cristin Rothfuss
  • Executive Vice President and General Counsel
  • --
  • Deirdre P. Connelly
  • Director
  • --
  • Dr. Claude Nicaise,M.D.
  • Independent Director
  • 553.34K
  • Richard J. Barry
  • Independent Director
  • 563.65K
  • Michael Chambers
  • Independent Director
  • 533.99K
  • Dr. Stephen L. Mayo, PhD
  • Independent Director
  • 546.49K
  • Dr. Hans Wigzell, M.D.,PhD
  • Independent Director
  • 546.99K
  • Dr. Kathryn Jean Boor, PhD
  • Independent Director
  • 543.58K
  • Dr. M. Kathleen Behrens Wilsey, PhD
  • Chairwoman of the Board
  • 594.99K
Heat List
US
Overall
Symbol
Price
% Chg

No Data